Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Aroa Biosurgery.
RELATED STOCKHEAD STORIES
Experts
ScoPo’s Powerplays: Who else needs help remembering the good times of ASX health stocks?
Health & Biotech
Check Up: Money managers are still bullish on Healthcare; here’s what they said
News
ASX Small Cap Lunch Wrap: Who applied for their forklift drivers test today?
Health & Biotech
Mesoblast has long been the one poster child for stem cell therapy. Now Cynata and other ASX stocks have emerged
News
Closing Bell: ASX drops again, hit by APRA lending restrictions and NZ rate hike
Director Trades
Directors’ Trades: Resources has been off the boil, but these directors just took a punt on their companies
Health & Biotech
Check up: Rhinomed (ASX:RNO) soars with NSW COVID contract, and genetic testing fails to impress
Health & Biotech
ASX health stocks: EMV’s brain scanner is completed and ready for testing, stock price jumps 16pc
Experts
These ASX stocks were the pick of the bunch at the Pinnacle Investment Summit
Health & Biotech
ScoPo’s Powerplays: Smaller capped health stocks are still in ‘no man’s land’, but Neuren jumps 18pc this week
Health & Biotech
Dr Boreham’s Crucible: Who’s winning and losing in the life sciences IPO Olympiad?
Health & Biotech
ScoPo’s Powerplays: Solid earnings for health stocks all round, but price action stays with larger caps
Health & Biotech
New breakthrough in stem cells research paves the way for ASX regenerative medicine stocks
News
Last Orders: ASX returns from Easter break with a gain
News
With America vaccinating 2 million a day, here are 3 ASX medtechs that will benefit as lockdowns are lifted
Experts
ScoPo’s health powerplays: ‘A great start to reporting season for healthcare’
Health & Biotech
